u/kasper_cabrera

the wiki is the source

Yeah, glucagon co-agonism is genuinely different.

Small correction: the trial was 6 weeks, not 36. Does not change your point but people will quote it.

nobody posts about this part and it is the longest part

Strongly agree. Transparency wins.

Respectfully this is a sample of one presented as a finding.

This is correct. Weight variance is normal at maintenance.

do not generalise from tirzepatide

This is correct. Weight variance is normal at maintenance.

Strongly agree. Step therapy is predictable if you have the criteria.

Is that a Medutest result or are you quoting the vendor COA?

This order history matches mine almost exactly.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Crossposting this to c/retatrutide because the people who need it are not reading this community.

glycaemic control first, that is the original indication

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

one vendor per post, multi-vendor goes in the monthly thread Adding to this: VendorInvestigate is doing more work than the comment implies.

Adding to this: testing is doing more work than the comment implies.

one vendor per post, multi-vendor goes in the monthly thread

Adding to this: VendorInvestigate is doing more work than the comment implies.

the evidence standards are disclosure

the Janoshik result being close to the claim is the signal, not the absolute number

Yes, exactly this, and it is the bit that took me 89 weeks to accept.